Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.
Oobli
Series B in 2022
Oobli specializes in the development of healthy, protein-based sweeteners sourced from exotic plants. These unique compounds offer a flavorful experience without the calories typically associated with sugar, making them a suitable alternative for health-conscious consumers. The protein sweeteners are produced through fermentation, ensuring they have no glycemic impact and do not disrupt the gut microbiome. Oobli has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for several of its proteins, reinforcing their commitment to safety and quality. By providing a delicious and low-calorie option, Oobli aims to transform the way individuals approach sweeteners, allowing for healthier choices in everyday consumption.
Faeth Therapeutics
Seed Round in 2022
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.
Oobli
Series A in 2020
Oobli specializes in the development of healthy, protein-based sweeteners sourced from exotic plants. These unique compounds offer a flavorful experience without the calories typically associated with sugar, making them a suitable alternative for health-conscious consumers. The protein sweeteners are produced through fermentation, ensuring they have no glycemic impact and do not disrupt the gut microbiome. Oobli has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for several of its proteins, reinforcing their commitment to safety and quality. By providing a delicious and low-calorie option, Oobli aims to transform the way individuals approach sweeteners, allowing for healthier choices in everyday consumption.
Yes Health
Series A in 2020
Yes Health is an all-mobile diabetes prevention program designed to empower people everywhere to start living healthier, happier lives. Its team is consists of physicians, health coaches and engineers that created a high-engagement program that’s low-cost, easy to follow and successful in preventing the onset of diabetes. People already living with the disease can also use it to successfully manage their symptoms. Yes Health helps people take charge of their health—and have fun doing it—by developing healthy habits that last a lifetime. Its mission is to stop diabetes.
Daye
Seed Round in 2019
Daye Ltd is a gynecological health company based in London, United Kingdom, founded in 2018. The company develops, manufactures, and markets female hygiene products under the Your Daye brand, specializing in innovative tampons designed to address period-related issues. Notably, Daye offers CBD-infused tampons that provide a natural alternative to traditional painkillers for managing menstrual cramps. In addition to its tampons, Daye is creating an at-home vaginal microbiome screening kit that allows women to test for infections and microbiome disruptions conveniently. This kit aims to empower women in monitoring their gynecological health, potentially reducing the risk of sexually transmitted infections, gynecological cancers, and complications related to fertility and IVF. Furthermore, Daye plans to launch a comprehensive digital platform focused on gynecological health, aiming to alleviate the challenges women face throughout their health journeys from menstruation to menopause.
Ripple Foods
Series C in 2018
Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has the creamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk. It was founded in 2014 and headquartered in Emeryville, California.
Ripple Foods
Series B in 2016
Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has the creamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk. It was founded in 2014 and headquartered in Emeryville, California.
Pique
Seed Round in 2015
Pique is a wellness and supplement company focused on providing scientific and plant-based solutions for health, wellness, and beauty. The company specializes in producing loose-leaf-grade instant tea products, utilizing advanced ingredient extraction and delivery technologies to create tea crystals that are both nutritional and organic. These tea crystals dissolve easily in hot or cold water, allowing consumers to enjoy fresh, flavorful organic tea conveniently. Pique's mission centers on empowering individuals to enhance their physical, mental, and spiritual well-being through knowledge and high-quality nutrients, drawing from the wisdom of traditional Chinese and Ayurvedic health systems.
Ripple Foods
Series A in 2015
Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has the creamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk. It was founded in 2014 and headquartered in Emeryville, California.
PHL
Seed Round in 2014
PHL is a non-active company listing.
Nu-Tek Salt
Private Equity Round in 2012
Nu-Tek Salt introduces reduced sodium and salt replacement products that incorporate a novel, patented technology and better tasting potassium chloride (NPC) to help lower the sodium content in your food applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.